LLY.SW
Price:
$955
Market Cap:
$1.09T
Eli Lilly and Company is a global pharmaceutical enterprise engaged in the discovery, development, and commercialization of human pharmaceutical products. Its diverse portfolio provides treatments across multiple therapeutic areas. In the field of diabetes care, the company offers a comprehensive range of insulins, such as Basaglar, various formulations of Humalog (including U-100, U-200, Mix 75/25, and Mix 50/50), insulin lispro, insulin lispro protamine, and insulin lispro mix 75/25. Additionally, its Humulin line features Humulin 70/30, Humulin N, Humulin R, and Humulin U-500. For the management of type 2 diabetes, key medications include Jardiance, Trajenta, and Trulicity. Its oncology d...[Read more]
Industry
Drug Manufacturers - General
IPO Date
1998-07-17
Stock Exchange
SIX
Ticker
LLY.SW
According to Eli Lilly and Company’s latest financial reports and current stock price. The company's current ROE is 92.58%. This represents a change of 297.66% compared to the average of 23.28% of the last 4 quarters.
The mean historical ROE of Eli Lilly and Company over the last ten years is 80.14%. The current 92.58% ROE has changed 15.53% with respect to the historical average. Over the past ten years (40 quarters), LLY.SW's ROE was at its highest in in the March 2019 quarter at 171.01%. The ROE was at its lowest in in the December 2017 quarter at -14.29%.
Average
80.14%
Median
60.40%
Minimum
-1.76%
Maximum
319.09%
Discovering the peaks and valleys of Eli Lilly and Company ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 870.38%
Maximum Annual ROE = 319.09%
Minimum Annual Increase = -1967.66%
Minimum Annual ROE = -1.76%
| Year | ROE | Change |
|---|---|---|
| 2025 | 77.78% | 4.24% |
| 2024 | 74.62% | 53.38% |
| 2023 | 48.65% | -17.03% |
| 2022 | 58.64% | -5.67% |
| 2021 | 62.16% | -43.38% |
| 2020 | 109.79% | -65.59% |
| 2019 | 319.09% | 870.38% |
| 2018 | 32.88% | -1967.66% |
| 2017 | -1.76% | -109.01% |
| 2016 | 19.54% | 18.24% |
The current ROE of Eli Lilly and Company (LLY.SW) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
67.02%
5-year avg
64.37%
10-year avg
80.14%
Eli Lilly and Company’s ROE is less than Roche Holding AG (37.12%), less than Novartis AG (29.64%), greater than Cosmo Pharmaceuticals N.V. (-1.21%), less than Abbott Laboratories (10.52%), greater than Lonza Group AG (-1.28%), less than Ypsomed Holding AG (28.54%), less than Siegfried Holding AG (16.14%), less than Ascom Holding AG (24.40%), less than Alcon Inc. (2.91%),
| Company | ROE | Market cap |
|---|---|---|
| 37.12% | $256.55B | |
| 29.64% | $218.77B | |
| -1.21% | $1.01B | |
| 10.52% | $125.45B | |
| -1.28% | $38.11B | |
| 28.54% | $4.54B | |
| 16.14% | $3.20B | |
| 24.40% | $194.04M | |
| 2.91% | $26.15B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Eli Lilly and Company using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Eli Lilly and Company or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Eli Lilly and Company's ROE?
How is the ROE calculated for Eli Lilly and Company (LLY.SW)?
What is the highest ROE for Eli Lilly and Company (LLY.SW)?
What is the 3-year average ROE for Eli Lilly and Company (LLY.SW)?
What is the 5-year average ROE for Eli Lilly and Company (LLY.SW)?
How does the current ROE for Eli Lilly and Company (LLY.SW) compare to its historical average?